Nigeria’s healthcare system is hampered by a reliance on imports and high costs. Mary Ogangwu of Codix Pharma emphasizes the necessity for robust policy measures to achieve local manufacturing targets for medicines and devices. Despite economic challenges, efforts to boost domestic production are underway, indicating a transformative potential for the healthcare sector in Nigeria and across Africa.
Nigeria’s heavy reliance on imported pharmaceuticals and medical equipment has rendered healthcare services more costly, limiting access for many citizens. Mary Ogangwu, Chief Operating Officer at Codix Pharma Limited, asserts that effective policies and government initiatives are essential to reach the targets of 70 percent local manufacturing of medicines and 30 percent of devices. Codix aims to provide innovative healthcare products that can serve Nigeria and the wider African market.
In 2024, Nigeria’s healthcare industry faced significant challenges, including economic hardship, inflation, and Naira depreciation, which increased the cost of imported healthcare products. This dependency led to supply chain disruptions and shortages, significantly impacting patients’ access to needed medications. The absence of some pharmaceutical companies from Nigeria has exacerbated health inequities.
Despite the difficulties of the past year, the Nigerian government has shown a commitment to boosting domestic healthcare manufacturing through a comprehensive strategy that incorporates regulatory reforms and investment opportunities. As 2025 unfolds, there are concerns over the withdrawal of USAID funding and its implications for healthcare systems that rely heavily on such aid. However, it is anticipated that proactive policy measures will help localize production.
Codix has distinguished itself as a pioneer in the healthcare sector, particularly in diabetes management, which includes the introduction of HbA1c testing in Nigeria. The company currently offers over 70 NAFDAC-registered products focusing on cardiometabolic health, rapid diagnostic tests, and wellness products. Codix’s strategic emphasis on local healthcare solution development and manufacturing has positioned it as a leader in African healthcare.
Since launching in 2008, Codix has constantly adapted and expanded its offerings, including establishing the Colexa Biosensor factory for blood glucose monitoring devices— a significant step toward local manufacturing. The company plans to further enhance local production capabilities, thereby reducing reliance on global supply chains while fostering economic growth.
Codix is dedicated to innovation in healthcare by continuously evolving and providing technology-enabled solutions that cater to local needs. The company recognizes the importance of collaboration and seeks partnerships with various stakeholders, including government agencies and private sector players, to foster healthcare advancements.
Nonetheless, significant challenges persist in the Nigerian healthcare sector, particularly access to low-interest financing and poor infrastructure. These factors hinder operational efficacy and competitiveness against global counterparts. Additionally, insufficient public healthcare funding remains a significant barrier to expanding the local manufacturing sector.
Looking ahead, Codix aspires to be the leading health tech company in Africa by 2030. The company is focused on strategic initiatives that promote backward integration and local healthcare solution development, aiming to meet not only Nigerian needs but also those of the broader African market.
In conclusion, Nigeria faces significant challenges in healthcare manufacturing due to heavy reliance on imports, economic instability, and insufficient healthcare funding. However, with government-backed initiatives to enhance local production and companies like Codix Pharma leading the charge in innovative healthcare solutions, there is potential for transformative change in the industry. Codix’s commitment to localization and strategic partnerships positions it well for future growth and improved healthcare access across Nigeria and Africa at large.
Original Source: businessday.ng
